Uterine Fibroid Embolization (UFE)


UFE

Uterine fibroid embolization (UFE) is a new therapy for the treatment of symptomatic uterine fibroids in many symptomatic women. Rely on the expertise of the ARFL Interventional Radiologists for your treatment.

For Appointments call 607-795-8080

Uterine fibroid embolization - The procedure is an alternative to hysterectomy and has a very high success profile as a treatment for bulk-related symptoms and bleeding related to fibroids. Our staff is very experienced in the UFE procedure and we tailor both care and follow-up to the needs of each patient.
UFE - Uterine Fibroid Embolization (Emira New York)

Overview:

  • 20-40% of women 35 and older have fibroids of significant size
  • Most frequent indication for hysterectomy in pre-menopausal women
  • 600,000 hysterectomies performed annually in US; 1/3rd due to fibroids
  • Most common tumor of the female genital tract
  • Prevalence in female population of childbearing age: 30% or higher
  • 10-20% of women with fibroids require therapy

Diagnosis

  • Suspected on pelvic examination
  • Confirmed with imaging (Ultrasound, MRI)

History

  • Embolization first performed 30 years ago
  • 1990's French gynecologist first requested uterine fibroid Embolization (UFE) prior to hysterectomy
  • Introduced into the USA in 1995 by Drs. McLucas and Goodwin
  • As of 2002, 20,000 UFE procedures performed worldwide

The Fertility Issue

  • It is unclear how fertility is affected
  • Multiple reports of successful pregnancies post embolization
  • Large multi-center trial needed
  • Myomectomy recommended for those wanting to preserve fertility

Child-bearing Age: Exceptions

  • Poor candidate for myomectomy: fibroids are too large and/or numerous
  • Failed myomectomy: symptoms reoccur or persist despite myomectomy
  • Poor surgical candidate

Results

  • Technical success: 98%
  • >87% effective in reducing bleeding
  • >93% effective in alleviating pain associated with fibroids
  • Expected decrease in fibroid volume is 50%
  • Patient satisfaction post UFE is 94%

Just the Facts..

  • Fibroid reoccurrence is exceedingly rare
  • UFE is not harmful to the uterus
  • In the setting of multiple fibroids, all are treated

Pre-embolization Evaluation

  • Gynecology evaluation.
  • Routine pre-angiography blood work
  • Pelvic MRI or ultrasound for baseline sizing and localization of lesions
  • Yearly pap smear
  • Endometrial biopsy if bleeding is the primary problem

How Does It Work?

  • Two uterine arteries supply the uterus
  • Tiny microspheres decrease blood flow to these hypervascular tumors
  • Starvation of fibroids results in shrinkage
  • UFE Procedure
  • Procedure time: 1.5 hrs
  • Patient asleep throughout entire procedure
  • Normal activity in 5-7 days
  • Procedure performed in radiology suite
  • Patient comfort is a high priority
  • Overnight observation for pain control.
  • Discharged to home the following morning

Post-Procedure Management

  • Routine overnight admission for pain control
  • Discharge after 24 hours

Expected Clinical Course

  • Pelvic pain and discomfort which should progressively decrease and resolve over 2 weeks
  • Fibroid size decreases over several months time

Uterine Cramping

  • All will experience a certain degree of uterine cramping following embolization.
  • Low grade cramping for up to 2 weeks; "roller-coaster" like.

Cost

  • Equivalent to cost of hysterectomy or open myomectomy
  • Covered by most insurances

Conclusion

  • Uterine artery embolization is safe and effective for alleviating symptoms from fibroid disease
  • >87% success at decreasing or resolving heavy bleeding or pressure symptoms
  • >93% effective in reducing pain
  • 94% patient satisfaction
  • Effect on future fertility has not been thoroughly studied

For Appointments call 607-795-8080

Find more information at: Ask For UFE
Find more information at: National Uterine Fibroids Foundation
Find more information at: Society of Interventional Radiology